Level B· Emerging clinical evidence with positive signalsClinical TrialEurope PMC

[Research progress of platelet-rich plasma in treatment of discogenic low back pain]

Huang H., Wang J., Liu X., Zhang J., Sun T., Li Z.

Clinical Trial on Back Pain, Disc Degeneration, published in Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi (2023) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Clinical Trial
Journal
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi (2023)
Reported sample size
—
Source database
Europe PMC
PMID
36941000
PMCID
PMC10027532
DOI
10.7507/1002-1892.202211047

Abstract (original English)

Objective To summarize the research progress of platelet-rich plasma (PRP) for the treatment of discogenic low back pain (DLBP). Methods The literature on the treatment of DLBP with PRP was extensively reviewed, and the classification, treatment mechanism, in vitro and in vivo experiments and clinical trial progress of PRP were summarized. Results According to the PRP composition, preparation methods, and physicochemical properties, there are five commonly used PRP classification systems at present. PRP is involved in delaying or reversing the progress of disc degeneration and pain control by promoting the regeneration of nucleus pulposus cells, increasing the synthesis of extracellular matrix, and regulating the internal microenvironment of degenerative intervertebral disc. Although several in vitro and in vivo studies have confirmed that PRP can promote disc regeneration and repair, significantly relieve pain, and even improve the mobility of DLBP patients. But the contrary conclusion has been reached in a few studies, and there are limitations to the application of PRP. Conclusion Current studies have confirmed the effectiveness and safety of PRP in the treatment of DLBP and intervertebral disc degeneration, as well as the advantages of PRP in terms of ease of extraction and preparation, low immunological rejection, high regenerative and repair capacity, and the ability to c

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence
HumansLow Back PainPlatelet-Rich PlasmaPain ManagementIntervertebral DiscIntervertebral Disc DegenerationNucleus Pulposus

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research